Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(50%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_3
1
25%
Ph phase_1
2
50%
Ph phase_4
1
25%

Phase Distribution

2

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(2)

Detailed Status

Active, not recruiting2
Completed2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (50.0%)
Phase 31 (25.0%)
Phase 41 (25.0%)

Trials by Status

active_not_recruiting250%
completed250%

Recent Activity

2 active trials
Showing 4 of 4
active_not_recruitingphase_1

Long Acting Neuraxial Peri-prostatic Block in Cancer

NCT06703437
active_not_recruitingphase_3

TARGET BP I Clinical Trial

NCT02910414
completedphase_4

Endoscopic Ultrasound-guided Celiac Plexus Neurolysis (EUS-CPN)With Alcohol in Unresectable Pancreatic Cancer: a Pilot Study

NCT00578279
completedphase_1

Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate)

NCT00037141

Clinical Trials (4)

Showing 4 of 4 trials
NCT06703437Phase 1

Long Acting Neuraxial Peri-prostatic Block in Cancer

Active Not Recruiting
NCT02910414Phase 3

TARGET BP I Clinical Trial

Active Not Recruiting
NCT00578279Phase 4

Endoscopic Ultrasound-guided Celiac Plexus Neurolysis (EUS-CPN)With Alcohol in Unresectable Pancreatic Cancer: a Pilot Study

Completed
NCT00037141Phase 1

Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate)

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4